Recognition highlights strong clinical progress and growing global validation of Incannex’s innovative approach to treating obstructive sleep apnea ...
Lead Radio-DARPin MP0712 progressing in Phase 1/2a trial with multiple clinical sites opening and initial clinical data expected in 2026New data on Radio-DARPins’ amenability to range of therapeutic ...
European Hematology Association (EHA) oral presentation to report 67% hematological improvement, durable transfusion ...